Anton Gopka is a Venture Capitalist and Deeptech Entrepreneur. He is a Co-Founder and Managing Partner at ATEM Capital, a New York-based Life Sciences venture firm. Prior to ATEM Mr. Gopka was Managing Partner at a $760 million strategic partnership with Domain Associates, one of the oldest US biotech venture groups, where he made 11 high-profile private investments (5 companies listed on NASDAQ, including Atea Pharmaceuticals which demonstrated 30x cash-on-cash return at IPO valuation, 2 companies sold, including Tobira Therapeutics, which was sold at an unprecedented premium of 19x of its current market cap to Allergan in Nov 2016).